Jubilant Pharmova
JUBLPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Shyam S Bhartia · MD: Hari S Bhartia · Listing date: Oct. 24, 1994 · Employees: 6000 · Noida · http://www.jubilantpharmova.com

Stock Price vs Company Growth
1d
2.5%
1w
2.1%
1m
5.5%
3m
20.4%
6m
63.2%
1y
102.6%
5y
7.3%
10y
15.1%
all
7.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

702 2.5%
539
741
Company Overview

Sales
6,622 Cr
Growth: 4.6%
Profit after Tax
37.9 Cr
Growth: -185.0%
Mid Cap
11,185 Cr
P/E: 293.8x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 6,622
Growth 4.6%
EBITDA 12.8%
P/S 1.7x
Dividend 1.2%
P/E 293.8x
Book Value ₹ 347
PEG Ratio 64.2x
ROE 0.7%
P/B 2.0x
Shareholding Pattern

Institutions
East Bridge Capital Master Fund Limited
4.52 %
East Bridge Capital Master Fund I Ltd
3.17 %
Government Pension Fund Global
2.65 %
Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund
1.07 %
Promoters
Spb Trustee Company Private Limited & Ss Trustee Company Private Limited (Jointly On Behalf Of Shyam Sunder Bhartia Family Trust)
20.52 %
Hsb Trustee Company Private Limited & Hs Trustee Company Private Limited (Jointly On Behalf Of Hari Shanker Bhartia Family Trust)
19.0 %
Miller Holdings Pte Ltd
3.28 %
Mav Management Advisors Llp
3.15 %
Nikita Resources Private Limited
2.2 %
Others
Rakesh Radheshyam Jhunjhunwala
3.14 %
Rakesh Radheshyam Jhunjhunwala
1.58 %
Rakesh Radheshyam Jhunjhunwala
1.57 %
Iepf
1.24 %
Increase    Decrease    No change
Company Profile Detailed

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals.Business segmentsPharmaceuticalsLife Science IngredientsDrug Discovery & Development SolutionsIndia Branded PharmaceuticalsAwards2012NDTV Profit Business Leadership Award 2012 for Corporate Social Responsibility.
Investors (141)
Followers (21)